JADE LEE: Open Payments
NPI 1891153235 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $637 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $350 |
| Alnylam Pharmaceuticals Inc. | 1 | $135 |
| Gilead Sciences, Inc. | 1 | $110 |
| Cipher Pharmaceuticals US LLC | 1 | $55 |
| Abbott Laboratories | 1 | $23 |
| Tonix Medicines, Inc. | 1 | $21 |
Products named: ONPATTRO, BREZTRI, FASENRA, Yeztugo, Natroba, AMPLATZER AMULET, TONMYA.
Industry payments across PA — which companies pay providers there.
